Search company, investor...
Binx Health company logo

Binx Health

mybinxhealth.com

Total Raised

$203.5M

Investors Count

20

Deal Terms

2

Funding, Valuation & Revenue

8 Fundings

Binx Health's latest funding round was a Series E for $104M on May 27, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/27/2021

Series E

$104M

0

FY undefined

8

11/10/2020

Series D - II

$99M

0

FY undefined

10

1/23/2017

Series D

$99M

0

FY undefined

10

1/29/2015

Series C

$99M

0

FY undefined

10

4/29/2014

Series B - II

0

FY undefined

10

Date

5/27/2021

11/10/2020

1/23/2017

1/29/2015

4/29/2014

Round

Series E

Series D - II

Series D

Series C

Series B - II

Amount

$104M

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

8

10

10

10

10

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Binx Health Deal Terms

2 Deal Terms

Binx Health's deal structure is available for 2 funding rounds, including their Series B from July 20, 2011.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Binx Health Investors

20 Investors

Binx Health has 20 investors. EQT Life Sciences invested in Binx Health's Series E funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/20/2011

5/27/2021

5
Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021)

Venture Capital

Netherlands

7/20/2011

5/27/2021

5
Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021)

Corporate Venture

New Jersey

11/10/2020

5/27/2021

2
Series D - II, Series E (2021)

Venture Capital

Spain

00/00/0000

00/00/0000

ArrowMark Partners

Subscribe to see more

Asset/Investment Management

Colorado

00/00/0000

00/00/0000

Hildred Capital Partners

Subscribe to see more

Family Office

New York

First funding

7/20/2011

7/20/2011

11/10/2020

00/00/0000

00/00/0000

Last Funding

5/27/2021

5/27/2021

5/27/2021

00/00/0000

00/00/0000

Investor

ArrowMark Partners

Hildred Capital Partners

Rounds

5
Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021)
5
Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021)
2
Series D - II, Series E (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Corporate Venture

Venture Capital

Asset/Investment Management

Family Office

Location

Netherlands

New Jersey

Spain

Colorado

New York

Compare Binx Health to Competitors

Coyote Bioscience Logo
Coyote Bioscience

Coyote Bioscience is dedicated to the development of portability of point-of-care molecular diagnostics, pathogen detection, and life science tools.

Visby Medical Logo
Visby Medical

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The company’s technology development program culminated in an instrument-free, single-use PCR platform that rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. Visby Medical technology also offers the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. It was founded in 2015 and is based in San Jose, California.

5
52 North Health

52 North Health develops NeutroCheck which is a fully-integrated clinical, AI- and medical device-based system for people living with cancer. It is a point-of-care medical device that can be used by patients outside of the hospital to monitor their risk of neutropenic sepsis, a potentially life-threatening complication of chemotherapy. The company was formerly known as Neutrocheck It was founded in 2018 and is based in Cambridge, U.K.

Ultrasight Logo
Ultrasight

Ultrasight develops an automated ultrasound solution that provides AI-based navigation, analysis, and diagnosis at the point of care.

Module Innovations Logo
Module Innovations

Module Innovations is a low-cost portable point-of-care diagnostic device for microbial infections like Urinary Tract Infections (UTI). The company leverages the strength of nano & bio, to create products in healthcare.

Ricovr Healthcare Logo
Ricovr Healthcare

RICOVR Healthcare is the creator of the XALIVA rapid diagnostics platform that provides high-quality, rapid diagnostics results using a small amount of saliva. The company’s product pipeline includes rapid point-of-care tests for Covid-19, THC & drugs-of-abuse, and infectious diseases. The company's patented biosensor platform uses a small drop of saliva to provide high-quality, cost-effective results in approximately five minutes, enabling employers, healthcare systems, and law enforcement to carry out cost-effective, non- invasive workplace and roadside testing.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.